Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

The use of a synthetic oxygen carrier-enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo.

Kimelman-Bleich N, Pelled G, Sheyn D, Kallai I, Zilberman Y, Mizrahi O, Tal Y, Tawackoli W, Gazit Z, Gazit D.

Biomaterials. 2009 Sep;30(27):4639-48. doi: 10.1016/j.biomaterials.2009.05.027. Epub 2009 Jun 21.

PMID:
19540585
2.

Oxygenated environment enhances both stem cell survival and osteogenic differentiation.

Benjamin S, Sheyn D, Ben-David S, Oh A, Kallai I, Li N, Gazit D, Gazit Z.

Tissue Eng Part A. 2013 Mar;19(5-6):748-58. doi: 10.1089/ten.TEA.2012.0298. Epub 2013 Jan 4.

PMID:
23215901
3.

Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering.

Park KH, Kim H, Moon S, Na K.

J Biosci Bioeng. 2009 Dec;108(6):530-7. doi: 10.1016/j.jbiosc.2009.05.021.

PMID:
19914589
4.

Enhancement of osteogenesis by concanavalin A in human bone marrow mesenchymal stem cell cultures.

Sekiya K, Nishimura M, Suehiro F, Nishimura H, Hamada T, Kato Y.

Int J Artif Organs. 2008 Aug;31(8):708-15.

PMID:
18825643
5.

Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.

Usami K, Mizuno H, Okada K, Narita Y, Aoki M, Kondo T, Mizuno D, Mase J, Nishiguchi H, Kagami H, Ueda M.

J Biomed Mater Res A. 2009 Sep 1;90(3):730-41. doi: 10.1002/jbm.a.32142.

PMID:
18570318
6.

Synthesis of a tissue-engineered periosteum with acellular dermal matrix and cultured mesenchymal stem cells.

Schönmeyr B, Clavin N, Avraham T, Longo V, Mehrara BJ.

Tissue Eng Part A. 2009 Jul;15(7):1833-41. doi: 10.1089/ten.tea.2008.0446.

PMID:
19125645
7.

The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.

Wang CZ, Chen SM, Chen CH, Wang CK, Wang GJ, Chang JK, Ho ML.

Biomaterials. 2010 Nov;31(33):8674-83. doi: 10.1016/j.biomaterials.2010.07.096. Epub 2010 Aug 16.

PMID:
20719378
8.

[A research on ectopic osteogenesis and vascularization of tissue engineered bone promoted by 1,25-(OH)2D3].

Li T, Wang J, Yang H.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007 Oct;21(10):1142-6. Chinese.

PMID:
17990787
9.
10.

The effect of ex vivo dynamic loading on the osteogenic differentiation of genetically engineered mesenchymal stem cell model.

Kimelman-Bleich N, Seliktar D, Kallai I, Helm GA, Gazit Z, Gazit D, Pelled G.

J Tissue Eng Regen Med. 2011 May;5(5):384-93. doi: 10.1002/term.324. Epub 2010 Aug 26.

PMID:
20740691
11.

Spatial distribution of mineralized bone matrix produced by marrow mesenchymal stem cells in self-assembling peptide hydrogel scaffold.

Hamada K, Hirose M, Yamashita T, Ohgushi H.

J Biomed Mater Res A. 2008 Jan;84(1):128-36.

PMID:
17600333
12.

Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation.

Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K.

Spine (Phila Pa 1976). 2007 Oct 15;32(22):2432-6.

PMID:
18090081
13.

Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue.

Kimura Y, Miyazaki N, Hayashi N, Otsuru S, Tamai K, Kaneda Y, Tabata Y.

Tissue Eng Part A. 2010 Apr;16(4):1263-70. doi: 10.1089/ten.TEA.2009.0322.

PMID:
19886805
14.

Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.

Hayashi C, Hasegawa U, Saita Y, Hemmi H, Hayata T, Nakashima K, Ezura Y, Amagasa T, Akiyoshi K, Noda M.

J Cell Physiol. 2009 Jul;220(1):1-7. doi: 10.1002/jcp.21760.

PMID:
19301257
15.

Ectopic osteogenesis by ex vivo gene therapy using beta tricalcium phosphate as a carrier.

Han D, Sun X, Zhang X, Tang T, Dai K.

Connect Tissue Res. 2008;49(5):343-50. doi: 10.1080/03008200802325029.

PMID:
18991087
16.

Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair.

Parsons P, Butcher A, Hesselden K, Ellis K, Maughan J, Milner R, Scott M, Alley C, Watson JT, Horner A.

J Orthop Trauma. 2008 Oct;22(9):595-604. doi: 10.1097/BOT.0b013e318188dbb7.

PMID:
18827588
17.

A novel strategy incorporated the power of mesenchymal stem cells to allografts for segmental bone tissue engineering.

Zou XH, Cai HX, Yin Z, Chen X, Jiang YZ, Hu H, Ouyang HW.

Cell Transplant. 2009;18(4):433-41. doi: 10.3727/096368909788809839.

PMID:
19622230
18.

Enhancement of in vivo bone regeneration efficacy of human mesenchymal stem cells.

Kang SW, Lee JS, Park MS, Park JH, Kim BS.

J Microbiol Biotechnol. 2008 May;18(5):975-82.

19.

Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.

Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, Noh I, Lee SH, Park Y, Sun K.

Biomaterials. 2007 Apr;28(10):1830-7. Epub 2007 Jan 8.

PMID:
17208295
20.

Enhanced osteogenic activity of bone morphogenetic protein-2 by 2-O-desulfated heparin.

Ratanavaraporn J, Tabata Y.

Acta Biomater. 2012 Jan;8(1):173-82. doi: 10.1016/j.actbio.2011.09.035. Epub 2011 Oct 6.

PMID:
22005328

Supplemental Content

Support Center